Prosecution Insights
Last updated: April 19, 2026

Arbutus Biopharma Corporation

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18883520 TARGETED COMPOSITIONS OLSON, ANDREA STEFFEL 1693 Non-Final OA Sep 12, 2024
18071353 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B WHITEMAN, BRIAN A 1636 Final Rejection Nov 29, 2022
17787089 SYNTHETIC PROCESSES AND INTERMEDIATES VANHORN, ABIGAIL LOUISE 1636 Non-Final OA Jun 17, 2022

Managing Arbutus Biopharma Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month